| PCLO altered in cohorts of …ALTERED_INderived26 of 26show fewer |
|---|
| → altered in cohorts of | Skin Squamous Cell Carcinoma 31 / 39 cases (79 %) · ssm · cscc_hgsc_bcm_2014 · largest of 2 cohorts | — | — | Skin Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cutaneous Melanoma 342 / 470 cases (73 %) · ssm · TCGA-SKCM · largest of 9 cohorts | — | — | Cutaneous Melanoma | 9 | Observed | gdc | graph → |
| → altered in cohorts of | Skin Basal Cell Carcinoma 70 / 126 cases (56 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Melanoma 65 / 144 cases (45 %) · ssm · mel_dfci_2019 · largest of 4 cohorts | — | — | Melanoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Diffuse Large B-Cell Lymphoma Unclassifiable 32 / 135 cases (24 %) · ssm · dlbcl_dfci_2018 | — | — | Diffuse Large B-Cell Lymphoma Unclassifiable | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Renal Cell Carcinoma 33 / 158 cases (21 %) · ssm · rcc_iatlas_immotion150_2018 | — | — | Renal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Endometrioid Adenocarcinoma 51 / 247 cases (21 %) · ssm · uec_cptac_gdc | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastroesophageal Junction Adenocarcinoma 103 / 518 cases (20 %) · ssm · stes_tcga_pub | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Carcinoma 102 / 517 cases (20 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Endometrial Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Adenocarcinoma 109 / 566 cases (19 %) · ssm · luad_tcga_pan_can_atlas_2018 · largest of 8 cohorts | — | — | Lung Adenocarcinoma | 8 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Non-Small Cell Carcinoma 219 / 1,144 cases (19 %) · ssm · nsclc_tcga_broad_2016 · largest of 2 cohorts | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Squamous Cell Carcinoma 88 / 484 cases (18 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 6 cohorts | — | — | Lung Squamous Cell Carcinoma | 6 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Small Cell Carcinoma 21 / 120 cases (18 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colon Adenocarcinoma 73 / 429 cases (17 %) · ssm · coad_tcga_gdc · largest of 3 cohorts | — | — | Colon Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastric Adenocarcinoma 80 / 478 cases (17 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Esophageal Adenocarcinoma 29 / 185 cases (16 %) · ssm · esca_tcga · largest of 4 cohorts | — | — | Esophageal Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Head and Neck Squamous Cell Carcinoma 79 / 515 cases (15 %) · ssm · hnsc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Hepatocellular Carcinoma 67 / 494 cases (14 %) · ssm · hcc_clca_2024 · largest of 7 cohorts | — | — | Hepatocellular Carcinoma | 7 | Observed | cbioportal | graph → |
| → altered in cohorts of | B-Cell Non-Hodgkin Lymphoma 35 / 297 cases (12 %) · ssm · mbn_sfu_2023 | — | — | B-Cell Non-Hodgkin Lymphoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colorectal Adenocarcinoma 97 / 1,015 cases (9.6 %) · ssm · crc_sysucc_2022 · largest of 3 cohorts | — | — | Colorectal Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cholangiocarcinoma 36 / 417 cases (8.6 %) · ssm · chol_icgc_2017 | — | — | Cholangiocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Diffuse Glioma 54 / 629 cases (8.6 %) · ssm · difg_glass · largest of 7 cohorts | — | — | Diffuse Glioma | 7 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cervical Squamous Cell Carcinoma 24 / 291 cases (8.2 %) · ssm · cesc_tcga_pan_can_atlas_2018 · largest of 2 cohorts | — | — | Cervical Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Multiple Myeloma 76 / 961 cases (7.9 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| → altered in cohorts of | Bladder Urothelial Carcinoma 35 / 474 cases (7.4 %) · ssm · blca_msk_tcga_2020 · largest of 5 cohorts | — | — | Bladder Urothelial Carcinoma | 5 | Observed | cbioportal | graph → |
| → altered in cohorts of | Small Lymphocytic Lymphoma 58 / 1,075 cases (5.4 %) · ssm · cll_broad_2022 · largest of 2 cohorts | — | — | Small Lymphocytic Lymphoma | 2 | Observed | cbioportal | graph → |